We allow biopharma to ask the right people the right questions at the right time

Because market access strategies should be rooted in the truth, not conjecture.

Formulary Insights helps biopharma manufacturers and investors navigate the US market access landscape

Clients leverage the combined expertise of our team and our panel of advisors to maximize their return on investment whether BD&L, pipeline development or inline product performance.

At Formulary Insights, all our panelists are active decision makers

No retirees. No loose affiliations. No misrepresentations.

Click below for a brief description of the value Formulary Insights can bring to your organization.



There is finally a better way.

Get REAL insights from ACTIVE market access decision makers in time to act.
Our market access experts are ready to go to work for you today.


Exclusive Agreement with the National Association of Specialty Pharmacy (NASP)

Formulary Insights transformed the payer market research landscape providing a better way to capture and deliver accurate payer insights.

3 Reasons US Payers Will Make 2021 a Banner Year for Biosimilars

Following a year which saw a 143% increase in launched biosimilars in the US, three reasons why payers will drive adoption further in 2021.

For Payer Research, High Stakes are the Mother of All Invention

As payers increasingly stifle new drug launches, investors in biopharmaceutical companies pursue better sources of insights.

A Better Path to Payer Insights

Payers have transformed the competitive marketplace, and biopharma companies need to regain their role as the authority on their products.


Experienced market access experts at your side from start-to-finish


Only active market access decision makers… no retirees, no loose affiliations


Agile research unleashes progressive learning and more actionable insights